Shivnath Bhaupatil Shinde

Title: Shivnath Bhaupatil Shinde: Innovator in Pharmaceutical Synthesis

Introduction

Shivnath Bhaupatil Shinde is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of novel synthetic routes for important medications. With a total of 2 patents, his work has the potential to impact the pharmaceutical industry positively.

Latest Patents

Shinde's latest patents include innovative methods for the synthesis of Raltegravir. The first patent details a novel synthetic route for the preparation of Raltegravir and its pharmaceutically acceptable salts, starting from 2-amino-2-methylpropanenitrile and oxadiazole carbonyl chloride. This process involves the formation of a pyrimidinone intermediate of formula (V). The second patent reiterates this innovative approach, emphasizing the importance of this synthetic route in the pharmaceutical field.

Career Highlights

Shivnath Shinde is currently associated with Emcure Pharmaceuticals Limited, where he continues to work on groundbreaking pharmaceutical innovations. His expertise in synthetic chemistry has positioned him as a valuable asset in the development of new therapeutic agents.

Collaborations

Shinde has collaborated with notable colleagues, including Mukund Keshav Gurjar and Swapnil Panditrao Sonawane. These collaborations have fostered a productive environment for innovation and research within the pharmaceutical sector.

Conclusion

Shivnath Bhaupatil Shinde's contributions to pharmaceutical synthesis exemplify the importance of innovation in medicine. His patents and ongoing work at Emcure Pharmaceuticals Limited highlight his commitment to advancing healthcare through scientific discovery.